A validated GC–MS method for the determination of Δ9-tetrahydrocannabinol and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in bile samples

Embed Size (px)

Text of A validated GC–MS method for the determination of Δ9-tetrahydrocannabinol and...

  • SHORT COMMUNICATION

    A validated GCMS method for the determinationof D9-tetrahydrocannabinol and 11-nor-D9-tetrahydrocannabinol-9-carboxylic acid in bile samples

    Ioannis Papoutsis Panagiota Nikolaou Artemisia Dona Constantinos Pistos

    Maria Stefanidou Chara Spiliopoulou Sotirios Athanaselis

    Received: 21 October 2011 / Accepted: 9 November 2011 / Published online: 3 December 2011

    Japanese Association of Forensic Toxicology and Springer 2011

    Abstract We present a validated gas chromatography-

    mass spectrometry method for the determination of D9-tet-rahydrocannabinol and 11-nor-D9-tetrahydrocannabinol-9-carboxylic acid in bile samples. The method includes protein

    precipitation with acetonitrile after enzymatic hydrolysis,

    and solid-phase extraction followed by silylation using

    N,O-bis(trimethylsilyl)trifluoroacetamide with 1% trimeth-

    ylchlorosilane. The limit of detection was 0.30 ng/ml and the

    limit of quantitation was 1.00 ng/ml. The calibration curves

    were linear within the dynamic range of 1.00500 ng/ml

    (R2 C 0.993) and the absolute recovery for both analytes

    was higher than 87.5%. Accuracy and precision were less

    than 8.8% and 8.2%, respectively. The developed method

    was applied for the analysis of bile samples obtained from 21

    forensic cases.

    Keywords D9-Tetrahydrocannabinol 11-Nor-D9-tetrahydrocannabinol-9-carboxylic acid Bile GCMS

    Introduction

    Cannabis, the most commonly used illicit drug throughout

    the world [1], is often implicated in forensic cases like deaths

    of drug addicts, driving under the influence of drugs, acci-

    dents, and others. The increasing use of cannabis threatens

    road safety because it is known to be a causative factor in

    some traffic accidents [26]. D9-Tetrahydrocannabinol

    (THC) is the main psychoactive constituent of the plant

    Cannabis sativa [7, 8] and it has a complex pharmacokinetic

    profile due to its high lipid solubility, protein binding and

    large distribution volume [3, 9]. THC is extensively metab-

    olized primarily to 11-hydroxy-D9-tetrahydrocannabinol(THC-OH), which is further metabolized to the carbox-

    ylic acid metabolite 11-nor-D9-tetrahydrocannabinol-9-car-boxylic acid (THCCOOH) [1013]. The concentrations of

    THC and its metabolites in biological samples correlate

    with recent drug use and impaired human performance or

    behavior; quantification of THC in blood is absolutely nec-

    essary in cases of accidents where victims or other involved

    persons are affected by cannabis [2, 11, 14]. Generally,

    plasma or whole blood concentrations of cannabinoids are

    required for the evaluation of driving ability under the

    influence of cannabis, for monitoring drug addicts under

    rehabilitation, and for the investigation of forensic cases

    [8, 12, 15]. In forensic cases, analysis of alternative matrices,

    such as bile, may be required especially when urine or blood

    samples are not available or cannabinoid blood concentra-

    tion data do not provide adequate answers to questions

    posed by the investigation [12]. The bile concentrations of

    drugs, including cannabinoids, are generally severalfold

    higher than the respective blood concentrations, so determi-

    nation of cannabinoids in bile remains an important post-

    mortem tool for documenting chronic cannabinoid use [16].

    Many analytical methods for determining cannabinoids

    in different biological matrices have been developed.

    Immunoassays are generally used for screening of urine

    samples for cannabis use, but the chromatographic confir-

    mation of positive results is mandatory [13]. For this

    purpose, gas chromatography (GC) [7, 11, 14, 15, 1719]

    or liquid chromatography (LC) [2, 4, 5, 8, 12, 13, 2025]

    methods using mainly mass spectrometry (MS) and MS/

    MS detectors have been used for the determination of THC

    I. Papoutsis P. Nikolaou (&) A. Dona C. Pistos M. Stefanidou C. Spiliopoulou S. AthanaselisDepartment of Forensic Medicine and Toxicology,

    School of Medicine, National and Kapodistrian University

    of Athens, 75 Mikras Asias, 115 27 Athens, Greece

    e-mail: pan_nik@hotmail.com

    123

    Forensic Toxicol (2012) 30:5158

    DOI 10.1007/s11419-011-0126-1

  • and its metabolites in blood [2, 4, 5, 8, 11, 12, 14, 17, 19,

    20, 22, 24, 25] or plasma [7, 13, 15, 18, 21], urine [11, 13,

    1921], oral fluid [20], and tissues [18, 23, 26]. To our

    knowledge, there is no validated method published con-

    cerning the determination of THC and its carboxylic acid

    metabolite THCCOOH in bile samples that could be used

    for the study of the distribution of cannabinoids and the

    establishment of cannabis use. The aim of this study was

    the development, optimization, and validation of a GCMS

    method for the determination of THC and THCCOOH

    concentrations in bile. The developed method was suc-

    cessfully applied in the analysis of bile samples from dead

    drug addicts during the investigation of the respective

    forensic cases.

    Materials and methods

    Chemicals and reagents

    Methanolic standard stock solutions of THC (1.0 mg/ml),

    THCCOOH (0.1 mg/ml), THC-d3 (0.1 mg/ml) and THC-

    COOH-d3 (1.0 mg/ml) were purchased from LGC Pro-

    mochem (Molsheim, France) and all standards were

    [99.9% pure. Bond Elut LRC Certify II Solid PhaseExtraction (SPE) columns were obtained from Varian

    (Houten, Netherlands). N,O-bis(trimethylsilyl)trifluoroace-

    tamide (BSTFA) with 1% trimethylchlorosilane (TMCS),

    pentafluoropropionic anhydride (PFPA) 99%, 2,2,3,3,3-

    pentafluoro-1-propanol (PFPOH) 97%, methyl iodide

    (CH3I) 99%, and b-glucuronidase (from Helix pomatia,400,000 units/g) were purchased from Sigma-Aldrich

    (Steinheim, Germany). The stock enzyme was diluted with

    1.0 M acetate buffer (pH 5.0) to prepare the working

    b-glucuronidase solution (100,000 units/ml). All solvents(methanol, hexane, ethyl acetate, acetone, acetonitrile,

    isooctane, acetic acid) were HPLC grade and were pur-

    chased from Merck (Darmstadt, Germany). Drug-free bile

    samples, verified as negative for drugs by GCMS, were

    pooled and used for the preparation of spiked calibrators

    and quality control (QC) samples.

    Preparation of standard solutions

    Combined stock solutions of THC and THCCOOH were

    diluted with methanol to prepare seven calibrator working

    solutions (0.02, 0.10, 0.20, 0.50, 1.50, 4.00, and 10.0 lg/ml).Bile samples for calibration curves were prepared by

    spiking pooled drug-free bile (950 ll) with 50 ll of theabove-mentioned working solutions, yielding concentra-

    tions for each analyte of 1.00, 5.00, 10.0, 25.0, 75.0, 200,

    and 500 ng/ml. QC working solutions were prepared at

    concentrations of 0.06, 2.00, and 8.00 lg/ml. Blank bilesamples (950 ll) were fortified with 50 ll of the appro-priate QC working solutions to give low (3.00 ng/ml),

    medium (100 ng/ml), and high (400 ng/ml) concentration

    QC samples for each analyte. A working internal standard

    solution containing THC-d3 and THCCOOH-d3 at con-

    centrations of 0.50 lg/ml was prepared by mixing theappropriate volumes of the corresponding stock solutions

    and then by diluting with methanol. Fresh working solu-

    tions were prepared on each day of analysis.

    Sample preparation

    A volume of 50 ll of the mixed working internal standardsolution (0.50 lg/ml) was added to the calibrator, QC, andreal bile samples (1.0 ml). All samples were vortex-mixed

    for 15 s. As a result, all calibrators, QC, and real samples

    contained 25.0 ng/ml of THC-d3 and THCCOOH-d3.

    Subsequently, 1 ml of 0.1 M acetate buffer (pH 7.0) and

    200 ll of working b-glucuronidase solution were added,the tubes were capped, vortex-mixed for 15 s, and stored at

    37C for 16 h. Following the enzymatic hydrolysis, pro-teins were precipitated with 3.0 ml of acetonitrile, added

    dropwise while vortex mixing. Then the samples were

    centrifuged at 2000 rpm for 5 min, the supernatant was

    decanted into a clean glass tube, and the solvent was

    evaporated under a gentle stream of N2 at 40C toapproximately 0.5 ml. The pH of all samples was adjusted

    to 7 with the addition of 5.0 ml of a mixture of 0.1 M

    acetate buffer (pH 7.0) with methanol (95:5, v/v, mixture

    A). Bond Elut LRC Certify II SPE columns were condi-

    tioned with 2 ml of methanol and 2 ml of mixture A prior

    to sample loading. The samples were applied to the col-

    umns at a flow rate of approximately 1.0 ml/min. The

    columns were washed subsequently with 2 ml of mixture A

    and 100 ll of acetone, and they were dried under highvacuum (C10 mmHg) for 3 min. THC was eluted twice

    with 2.0 ml of a freshly prepared mixture of hexane:ethyl

    acetate (90:10, v/v). The THC eluates were collected in

    clean tubes and evaporated to dryness under a gentle

    stream of N2 at 40C. Then the columns were washed againwith 3.0 ml of methanol 50% and 100 ll of ethyl acetateand they were dried under high vacuum (C10 mmHg) for

    3 min. THCCOOH was eluted twice with 2.0 ml of a

    freshly prepared mixture of hexane:ethyl acetate:acetic

    acid (90:10:1, v/v/v). The THCCOOH eluates were also

    collected in clean tubes and evaporated to dryness under a

    gentle stream of N2 at 40C. All the residues were deriv-atized by adding 30 ll of acetonitrile and 30 ll of BSTFAwith 1% TMCS, vortex mixing, and heating at 70C for30 min. After cooling the tubes, the samples were injected

    (1.